Skip to content

Category: xlrp

AGTC Launches XLRP Gene Therapy Clinical Trial at Five Sites in U.S.

Source: Foundation Fighting Blindness Blog – Eye on the Cure – AGTC Launches XLRP Gene Therapy Clinical Trial at Five Sites in U.S. Audio version:Applied Genetic Technologies Corporation (AGTC) is now recruiting for its Phase 1/2 gene therapy clinical trial for males with X-linked retinitis pigmentosa (XLRP) caused by…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

MeiraGTx Treats First Patient in XLRP Gene-Therapy Trial

Source: Foundation Fighting Blindness Blog – Eye on the Cure – MeiraGTx Treats First Patient in XLRP Gene-Therapy Trial MeiraGTx, a gene-therapy company in London and New York City, has treated its first patient in a gene-therapy clinical trial for people with X-linked retinitis pigmentosa (XLRP) caused by mutations…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest